Literature DB >> 1963641

Clues to the multi-phasic inhibitory action of botulinum neurotoxins on release of transmitters.

J O Dolly1, A C Ashton, C McInnes, J D Wadsworth, B Poulain, L Tauc, C C Shone, J Melling.   

Abstract

1. With the aim of gaining insight into the mechanism of Ca2(+)-dependent secretion, inhibition of transmitter release by botulinum neurotoxins or their fragments was studied at mammalian motor nerve terminals, cerebrocortical synaptosomes and PC-12 cells. 2. Relative to BoNT type A, the feeble neuromuscular paralytic activity of its two chains and the lack of activity observed with a proteolytic fragment, H2L (lacking H1, the C-terminal half of the heavy chain) highlight a requirement of the intact, disulphide-linked dichain protein for efficient targetting (binding/uptake) to peripheral cholinergic nerve endings. 3. In PC-12 cells, the renatured light chain alone proved equally potent as the whole toxin in reducing Ca2(+)-evoked noradrenaline release, when digitonin-permeabilization was used to overcome the uptake barrier. Treatment of BoNT A with 10 mM dithiothreitol, under non-denaturing conditions, was not very effective in reducing its inter-chain disulphide bond(s) and had little influence on the level of inhibition seen. 4. Altering the intra-synaptosomal concentrations of cyclic nucleotides (c-AMP, c-GMP) or protein kinase C activity failed to affect the reduction of Ca2(+)-dependent K(+)-stimulated noradrenaline release caused by BoNT A or B. On the other hand, raising the cytosolic Ca2+ concentration with the ionophore A23187 reversed the inhibitory effect of BoNT A to a greater extent than that of type B, revealing differences in their actions. 5. Whereas BoNT-induced decrease of Ca2(+)-dependent K(+)-evoked release of noradrenaline was unaffected by destruction of the actin-based cytoskeleton in synaptosomes with cytochalasin D, disassembly of microtubules with colchicine, nocodazole or griseofulvin antagonised the intracellular action of type B but not A. It is speculated that BoNT B blocks transmitter release by interfering with the proposed detachment of synaptic vesicles from microtubules. Establishing the precise involvement of tubulin in the toxin's action may provide a valuable clue to the mechanism of neurotransmitter release or its control.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963641

Source DB:  PubMed          Journal:  J Physiol (Paris)        ISSN: 0021-7948


  6 in total

1.  A capillary electrophoresis technique for evaluating botulinum neurotoxin B light chain activity.

Authors:  Michael Adler; Harlan F Shafer; Heather A Manley; Brennie E Hackley; James D Nicholson; James E Keller; Michael C Goodnough
Journal:  J Protein Chem       Date:  2003-07

Review 2.  From poison to remedy: the chequered history of botulinum toxin.

Authors:  F J Erbguth
Journal:  J Neural Transm (Vienna)       Date:  2007-04-26       Impact factor: 3.575

3.  Small molecule metalloprotease inhibitor with in vitro, ex vivo and in vivo efficacy against botulinum neurotoxin serotype A.

Authors:  Alan R Jacobson; Michael Adler; Nicholas R Silvaggi; Karen N Allen; Genessa M Smith; Ross A Fredenburg; Ross L Stein; Jong-Beak Park; Xiaochuan Feng; Charles B Shoemaker; Sharad S Deshpande; Michael C Goodnough; Carl J Malizio; Eric A Johnson; Sabine Pellett; William H Tepp; Saul Tzipori
Journal:  Toxicon       Date:  2017-07-08       Impact factor: 3.033

4.  Botulinum type A neurotoxin digested with pepsin yields 132, 97, 72, 45, 42, and 18 kD fragments.

Authors:  J A Gimenez; B R DasGupta
Journal:  J Protein Chem       Date:  1993-06

5.  Long term effects of intra-articular botulinum toxin A for refractory joint pain.

Authors:  M L Mahowald; J A Singh; D Dykstra
Journal:  Neurotox Res       Date:  2006-04       Impact factor: 3.911

6.  Pepsin fragmentation of botulinum type E neurotoxin: isolation and characterization of 112, 48, 46, and 16 kD fragments.

Authors:  J A Giménez; B R DasGupta
Journal:  J Protein Chem       Date:  1992-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.